{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5b0fd1107b67904376d520f7/615583309dca4300134524a9?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Investing in Life Sciences and Health Care with Deepbridge's Andrew Aldridge ","description":"<p>The UK Investor Magazine Podcast welcomes Andrew Aldridge, a Partner at Deepbridge Capital. </p><p><br></p><p>Deepbridge Capital is the manager of a £200 million range of tax-efficient EIS and SEIS funds including the Deepbridge Life Sciences EIS, Deepbridge Life Sciences SEIS and Deepbridge Technology Growth EIS.</p><p><br></p><p>Andrew joins the Podcast to focus on their Life Sciences funds which account for roughly £50m of their £200m investments.</p><p><br></p><p>We discuss how the pandemic has increased investment in Life Sciences and Health Care as investors seek out opportunities in the evolving health care system.</p><p><br></p><p>Andrew highlights a selection of companies Deepbridge have added to their portfolios and the key trends they see developing in the sector.</p><p><br></p><p>We explore the most important factors Deepbridge consider when selecting for their portfolios and delve into the journey's of some of their portfolio companies. </p>","author_name":"UK Investor Magazine"}